Validating the long-range chromatin interactions between rs13239597 and IRF5
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The SNP rs13239597 was located ~118 kb far away from its candidate target gene IRF5. We IRF5 using capture Hi-C and Hi-C data across multiple blood cell lines [23] [24] [25] [26] . We observed 3 4 6 that rs13239597 strongly interacted with the distal gene IRF5 in five different cell lines 3 4 7 (GM12878, CD34, K562, IMR90 and MCF7) ( Figure 3A and Table S2 ). We also analyzed 3 4 8 topologically associating domains (TADs) surrounding rs13239597 locus, and found that 3 4 9 rs1323957-IRF5 circuit was located within a conserved TAD with a size of 1.16 Mb in Genotyping assay revealed that B lymphocyte-derived Raji cell line is homozygous CC ( Figure 3C ). To directly validate the chromatin interactions between rs13239597 and IRF5, we performed 3C assay in Raji cell line. When anchored at IRF5 promoter, rs13239597 any of the other 10 neighboring KpnI sites tested ( Figure 3D ). Consistently, when anchored at 3 5 8 rs13239597 enhancer region, IRF5 promoter region showed the strongest interaction with 3 5 9 rs13239597 enhancer region in comparison with other sites tested ( Figure 3D ). We also 3 6 0 performed 3C assay in U2OS cell line, and detected relatively higher chromatin interactions 3 6 1 between rs13239597 and IRF5 compared with Raji cell line, which might indicate the 3 6 2 superior allele-specific long-range chromatin loop formation between rs13239597-A and Rs13239597 acts as an allele-specific enhancer regulating IRF5 expression independent To experimentally validate the allelic regulation between rs13239597 and IRF5, we 3 6 8 compared the regulatory activity of genomic fragment containing different genotypes of 3 6 9 rs13239597 on IRF5 expression using dual-luciferase reporter assays in Raji cell line. We
found that both alleles of rs13239597 could reinforce IRF5 expression (P < 0.01, Figure 4A ).
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Particularly, rs13239597-A allele had significantly enhanced effect on IRF5 expression 3 7 2 compared with rs13239597-C allele (Fold change = 2.06, P < 0.008, Figure 4A ), which is consistent with our eQTL analysis results ( Figure 2 and Table 1 ). Genotyping assay revealed that HEK293T cell line is homozygous CC genotype for rs13239597 ( Figure S2 ). We further HEK293T cells in which significantly higher IRF5 expression was observed on rs13239597-
A allele compared with rs13239597-C allele (Fold change = 1.5, P < 0.01, Figure 4B ).
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However, no significant enhanced luciferase activity was observed on rs13239597-C allele compared with the IRF5 promoter-only plasmid (P > 0.05, Figure 4B ). We also compared the HEK293T cells, and detected no significant effect of rs13239597-A allele on TNPO3 3 8 2 expression although different regulatory activities between two alleles of rs13239597 were 3 8 3 detected (P < 0.02, Figure 4B ). Collectively, these luciferase results suggested the allelic 3 8 4 strong enhancer activity of rs13239597-A allele on IRF5 instead of TNPO3. To further validate the allelic enhancer activity of rs13239597 on IRF5, we deleted the
genomic fragment harboring rs13239597 using CRISPR-Cas9 in three different cell lines (Raji, HEK293T and U2OS). We observed no significant alterations of IRF5 expression in ( Figure 4C and 4D ). By contrast, we detected significantly decreased IRF5 expression in the 3 9 1 rs13239597-AC deleted U2OS cell lines (P < 0.001, Figure 4E ), supporting the allele-specific 3 9 2 enhancer activity of rs13239597-A on IRF5. We also detected significantly decreased expression of TNPO3 in rs13239597-CC deleted
cell lines ( Figure 4C-4E ), raising the question whether the detected regulatory activity of 3 9 6 rs13239597 on IRF5 was fictitious due to the intermediary effect of TNPO3. To further
demonstrate the direct enhancer activity of rs13239597-A on IRF5 independently of TNPO3,
we firstly suppressed TNPO3 expression in rs13239597-AC U2OS cells, and found no 3 9 9
significant effect on IRF5 expression ( Figure 4F ). We further deleted rs13239597-AC IRF5 expression (P < 0.001, Figure 4G ). Taken together, these experimental results We next explored the functional mechanism underlying rs13239597 as the strong allele-
specific enhancer on IRF5. The motif analysis revealed that EVI1 could specifically bind to 4 0 8 rs13239597-A allele ( Figure 5A ). To validate allelic binding affinity of EVI1 on rs13239597, 4 0 9
we performed chromatin immunoprecipitation allele-specific quantitative PCR (ChIP AS-
qPCR) assay in rs13239597-AC U2OS cell line. We found that EVI1 could bind to 4 1 1 rs13239597 region in U2OS ( Figure 5B ). Particularly, EVI1 was preferentially recruited to 4 1 2 the rs13239597-A allele compared with rs13239597-C allele (Fold change = 1.8, P < 0.001,
Figure 5B). To further assess the transcriptional influence of rs13239597 on IRF5 expression mediated by EVI1, we suppressed EVI1 by shRNA in both U2OS cells and HEK293T cells. expression in U2OS cells (P < 0.05, Figure 5C ) while no obvious disturbance of IRF5 4 1 7 expression in HEK293T cells ( Figure 5D ). We further co-transfected the EVI1 shRNA To compare the IRF5 expression between SLE patients and healthy individuals, we screened
the IRF5 expression in whole blood samples of three SLE genome-wide gene expression was found in SLE patients compared with healthy individuals in all three datasets (P = 1.272
× 10 -4 in GSE61635, P = 0.001 in GSE39088 and P = 0.019 in GSE65391, Figure 5F ), which
was consistent with that the risk allele-A of rs13239597 could augment IRF5 expression. we demonstrated that rs13239597 located in TNPO3 promoter region functions as an allele- loop formation. We corroborated that the enhancer activity of rs13239597 was elevated by specific functional role of rs13239597 leading to the IRF5 hyperactivation followed by the 4 4 3 production of pathogenic antibodies against self-tissues ( Figure 6A ). In our study, rs13239597 located in the promoter region of TNPO3 functions as an allele-
specific functional enhancer, which highlights dual roles of its functionality. Our study revealed that the transcription factor EVI1 could preferentially bind to rs13239597- and OR = 1.567 for SSc) [8] . Consistently, our study revealed that EVI1 strongly binds to the
risk allele (rs13239597-A) and subsequently promotes IRF5 expression, high expression of
which produces pathogenic antibodies leading to SLE and SSc. In summary, we provided a new mechanistic insight that rs13239597 acts as an allele-specific feasible approach to investigate the role of a noncoding functional variant and its target distal
gene through a series of integrated bioinformatics data analyses and various functional assays.
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We anticipate that the similar approach could be the further investigation of functional 4 8 2 mechanisms underlying disease risk variants associated with more human complex diseases
to fulfill the gap of GWASs. We believe that our findings might fulfill the current issues 
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